Related Experiment Videos

Increased cyclooxygenase-2 expression in juvenile polyposis syndrome

W Arnout van Hattem1, Lodewijk A A Brosens, Susan Y Marks

  • 1Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands. W.A.vanHattem@umcutrecht.nl

Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|January 7, 2009
PubMed

Insights

Juvenile polyposis syndrome (JPS) polyps show higher cyclooxygenase-2 (COX-2) expression than sporadic polyps. This difference in COX-2 expression may have clinical implications for managing these conditions.

Area of Science:

  • Gastroenterology
  • Oncology
  • Molecular Biology

Background:

  • Juvenile polyps can be associated with Juvenile Polyposis Syndrome (JPS) or occur sporadically.
  • JPS, an autosomal-dominant condition, involves multiple gastrointestinal polyps and carries an increased risk of malignancy.
  • Cyclooxygenase-2 (COX-2) is implicated in gastrointestinal tumorigenesis and its inhibition can impact polyp regression.

Purpose of the Study:

  • To investigate the role of COX-2 in juvenile polyps.
  • To compare COX-2 expression in polyps from JPS patients versus sporadic juvenile polyps.

Main Methods:

  • Tissue microarray analysis was used to assess COX-2 expression in 24 JPS patients and 26 patients with sporadic juvenile polyps.
  • Expression of Hu-antigen R and CCAAT/enhancer-binding protein beta, associated with COX-2, was also investigated.

Main Results:

  • COX-2 expression was significantly increased in JPS patients compared to those with sporadic juvenile polyps (P < .001).
  • JPS patients with a BMPR1A mutation exhibited higher COX-2 levels than JPS patients without detected mutations.
  • High COX-2 levels correlated with increased Hu-antigen R expression in JPS polyps (P = .022).

Conclusions:

  • Distinct COX-2 expression profiles exist between JPS-associated and sporadic juvenile polyps.
  • These differential expression patterns may hold clinical significance for patient management.
Abstract

Related Concept Videos

Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
Pleiotropy01:33

Pleiotropy

Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
Chronic Pancreatitis II: Pathophysiology01:21

Chronic Pancreatitis II: Pathophysiology

Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...